行业资讯精选 83TechCrunch AI
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials· Enveda获3.11亿美元融资推AI药物临床
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
📎 发布于 09-24 03:31🔗 阅读原文(techcrunch.com)